Bruker’s timsTOF Pro mass spectrometer receives EuPA technology award at Proteomic Forum 2019

Bruker announces that on Wednesday, March 27th, its ultra-high sensitivity, high-throughput 4D proteomics platform, the timsTOF Pro mass spectrometer received the prestigious technology award during the Proteomic Forum 2019/XIII. Annual Congress of the European Proteomics Association (EuPA) in Potsdam, Germany. The EuPA Technology Award is given to recognize a team with an outstanding contribution in private industry who played a key role in commercialization of a proteomics technology.

In his acceptance remarks Dr. Gary Kruppa, Vice President for Proteomics at Bruker Daltonics credited R&D groups led by Dr. Melvin Park, and Oliver Raether with the invention and development of the trapped ion mobility (TIMS) technology. The TIMS technology is the basis for the PASEF method which was invented and developed by the same teams in collaboration with the group of Prof. Matthias Mann at the Max Planck Institute for Biochemistry in Martinsried, Germany.

Dr. Kruppa further commented:

Bruker’s entire team supporting development, marketing and other commercialization aspects of the timsTOF Pro is delighted to have its innovation recognized by the proteomics community.”  

Shown in the picture receiving the award are (from left to right): Prof. Uwe Voelker, conference co-chair and head of the Department of Functional Genomics at the University of Greifswald; Dr. Pierre-Olivier Schmitt, market manager for proteomics at Bruker Daltonics; Dr. Gary Kruppa; Dr. Scarlet Koch, market manager for proteomics at Bruker Daltonics; Karl Mechtler, EuPA Executive Committee member of EuPA and Head of the Protein Chemistry Facility at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bruker Life Sciences Mass Spectrometry. (2019, June 19). Bruker’s timsTOF Pro mass spectrometer receives EuPA technology award at Proteomic Forum 2019. News-Medical. Retrieved on April 19, 2024 from https://www.news-medical.net/news/20190403/Brukers-timsTOF-Pro-mass-spectrometer-receives-EuPA-technology-award-at-Proteomic-Forum-2019.aspx.

  • MLA

    Bruker Life Sciences Mass Spectrometry. "Bruker’s timsTOF Pro mass spectrometer receives EuPA technology award at Proteomic Forum 2019". News-Medical. 19 April 2024. <https://www.news-medical.net/news/20190403/Brukers-timsTOF-Pro-mass-spectrometer-receives-EuPA-technology-award-at-Proteomic-Forum-2019.aspx>.

  • Chicago

    Bruker Life Sciences Mass Spectrometry. "Bruker’s timsTOF Pro mass spectrometer receives EuPA technology award at Proteomic Forum 2019". News-Medical. https://www.news-medical.net/news/20190403/Brukers-timsTOF-Pro-mass-spectrometer-receives-EuPA-technology-award-at-Proteomic-Forum-2019.aspx. (accessed April 19, 2024).

  • Harvard

    Bruker Life Sciences Mass Spectrometry. 2019. Bruker’s timsTOF Pro mass spectrometer receives EuPA technology award at Proteomic Forum 2019. News-Medical, viewed 19 April 2024, https://www.news-medical.net/news/20190403/Brukers-timsTOF-Pro-mass-spectrometer-receives-EuPA-technology-award-at-Proteomic-Forum-2019.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lipid Nanoparticles (LNPs) and DNA delivery – unlocking the future of medical research